Related Experiment Videos
Ergotism treated with hyperbaric oxygen and continuous epidural analgesia
Acta Anaesthesiologica Scandinavica. Supplementum
|January 1, 1978
Summary
Hyperbaric oxygen therapy and epidural analgesia effectively restored circulation and tissue vitality in patients with severe ergotamine-induced peripheral ischemia. This combined treatment is recommended for severe ergotism cases.
Area of Science:
- Vascular Surgery
- Hyperbaric Medicine
- Pain Management
Background:
- Ergotamine abuse can lead to severe peripheral ischemia.
- Standard treatments for ergotamine-induced ischemia have shown limited success.
- Patients often require specialized interventions for limb salvage.
Purpose of the Study:
- To evaluate the efficacy of hyperbaric oxygen therapy (HBOT) combined with epidural analgesia for severe ergotamine-induced peripheral ischemia.
- To assess the impact of this combined treatment on tissue circulation and viability.
- To determine the long-term outcomes in patients treated with HBOT and epidural analgesia.
Main Methods:
- Eight patients with severe ergotamine-induced peripheral ischemia received HBOT at 3 atmospheres absolute (ATA) of oxygen for 1 hour, 2-3 times daily.
- Epidural blocks were administered for analgesia in cases of severe pain.
- Circulation and tissue vitality were monitored throughout the treatment period.
Main Results:
- All eight patients experienced restoration of circulation and tissue vitality.
- One patient required tarsal amputations six months post-treatment.
- No other adverse events or complications were reported during the study period.
Conclusions:
- Hyperbaric oxygen therapy in combination with epidural analgesia is a highly effective treatment for severe ergotamine-induced peripheral ischemia.
- This therapeutic approach can significantly improve outcomes and potentially prevent amputations.
- The combined treatment offers a promising solution for managing this critical condition.